print this page | email this page
Glaucoma in the News
News from the world of eye health.
On World Sight Day, a Reminder that Knowing Your Risks Can Save Your Sight
World Sight Day this year is dedicated to raising awareness of women and eye health. Worldwide, 314 million people are visually impaired, of whom 45 million are blind. Nearly two-thirds of people affected by vision loss are female.
Researchers Identify Gene Variant Linked to Glaucoma
An international team, led by researchers from the University of California, San Diego School of Medicine and the National Eye Institute, has discovered gene variants for glaucoma in a black population.
Free Medicines Program for Newly Unemployed Americans
Nearly 46 million Americans lacked health insurance in 2007. It is thought that this number has grown substantially due to the economic downturn. Pfizer, makers of the glaucoma drug Xalatan, has launched a program to address the needs of patients who have become recently unemployed.
Stanford’s Kuldev Singh, MD Elected to Chair the Glaucoma Research Foundation
Kuldev Singh, MD, MPH, Professor of Ophthalmology and Director of the Glaucoma Service at the Stanford University School of Medicine, began serving today as the new Board Chair of the Glaucoma Research Foundation (GRF). He was elected Chairman at the recent Board of Directors Annual Meeting. GRF is America’s oldest national institution dedicated solely to preventing vision loss from glaucoma.
Preventing Delay to Follow-up for Patients with Glaucoma
In a new report, UK eye care specialists are being urged to review their systems for the diagnosis and management of open-angle glaucoma in order to preserve the vision of glaucoma patients.
Your Eyes Are the Windows to Your Health
A recent study by the National Eye Institute found that more than 11 million Americans have common vision problems such as nearsightedness, farsightedness, astigmatism, and presbyopia. While this number may sound alarming, the good news is that common vision problems can be detected through a comprehensive dilated eye exam and can be corrected.
David Calkins Promoted to Director of Research for the Vanderbilt Eye Institute
Catalyst For a Cure Principal Investigator David J. Calkins, PhD was promoted to Director of Research for the Vanderbilt Eye Institute, effective April 1st. Dr. Calkins has a distinguished background, receiving his PhD at University of Pennsylvania and then doing his postdoctoral work at Johns Hopkins.
Ophthalmology Times Europe features article on Catalyst For a Cure in April issue
“If The Glaucoma Research Foundation can play any part in getting researchers to collaborate and share ideas, in addition to finding a cure for glaucoma, then our work is done,” Thomas Brunner, CEO of The Glaucoma Research Foundation told Ophthalmology Times Europe. His statement is neither fanciful nor wishful thinking as collaboration is the basis for a unique research model, Catalyst for a Cure, which is funded by The Glaucoma Research Foundation.
Online Video Tips from Leading Glaucoma Experts
A new online series of short educational videos launched today, World Glaucoma Day, on the website “All Eyes On Glaucoma.” The video series features short messages from leading global glaucoma experts.
Vision Community Unites to Observe World Glaucoma Day on Capitol Hill
To recognize the second annual World Glaucoma Day (WGD) on March 12, the Association for Eye and Vision Research (AEVR) sponsored a March 10 Capitol Hill briefing to educate Members of Congress and their staffs. The event was timely, as the Senate was passing a bill which allocates nearly $200 million more for vision research.